| |
| |
|
|
Predictive biomarkers for anthacycline
benefit in early breast cancer
Joseph Ragaz, MD, FRCPC
More>>
|
|
Measuring the quality of care provided
to patients with colorectal cancer
Robin Urquhart, MSc and Eva Grunfeld,
MD, DPhil, FCFP
More>>
|
 |
Innovations in assessment and management
of breakthrough cancer pain
Challenges and successes
Neil A. Hagen, MD, FRCPC
More>>
Funded by an educational grant from
Meda Valeant Pharma
Canada Inc.
|
 |
|
|
|
|
We welcome your
letters and suggestions for future articles.
Please address
correspondence to Emily Andrews, Managing Editor, at andrews@parkpub.com
|
| |
Back
to Top of Page |
|
| |
|
Reports from MASCC
and ASCO
SUPPORTIVE
CARE: symptom patterns in patients with advanced cancer
Maragret Fitch, MScN, PhD and
Barry D. Bultz, PhD, RPsych
COLON CANCER:
biochemical markers
Hagen Kennecke, MD, FRCPC
BREAST
CANCER: nab-paclitaxel in metastatic disease
Susan
Dent, MD, BSc, FRCPC
RENAL
CANCER: advanced disease
Bernhard
Eigl, MD, FRCPC
More>>
|
|
|
|
